These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3979047)

  • 1. Contact allergic reaction to valerate esters of betamethasone and hydrocortisone.
    Koch EM
    Contact Dermatitis; 1985 Jan; 12(1):58. PubMed ID: 3979047
    [No Abstract]   [Full Text] [Related]  

  • 2. Clobetasone butyrate compared with betamethasone valerate in the treatment of atopic and contact dermatitis.
    Fredriksson T; Nordin K
    Curr Med Res Opin; 1979; 6(5):322-4. PubMed ID: 540522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of bufexamac cream versus betamethasone valerate cream in contact dermatitis: a double-blind trial.
    Wolf-Jürgensen P
    Curr Med Res Opin; 1979; 5(10):779-84. PubMed ID: 373992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contact dermatitis caused by creams containing clobetasol propionate].
    Camarasa JG; Serra-Baldrich E
    Med Cutan Ibero Lat Am; 1988; 16(4):328-30. PubMed ID: 3068444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of acid mucopolysaccharide synthesis by hydrocortisone, hydrocortisone 17-butyrate and betamethasone 17-valerate.
    Saarni H; Hopsu-Havu VK
    Br J Dermatol; 1977 Nov; 97(5):505-7. PubMed ID: 145236
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trial comparing hydrocortisone 17-butyrate to betamethasone 17-valerate in a series of patients with eczematous skin diseases.
    Thormann J; Brodthagen H
    Dermatologica; 1976; 152 Suppl 1():209-14. PubMed ID: 782955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatographic assay of betamethasone 17-valerate and its degradation products.
    Li Wan Po A; Irwin WJ; Yip YW
    J Chromatogr; 1979 Sep; 176(3):399-405. PubMed ID: 546923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study.
    Mercader-García P; Pastor-Nieto MA; García-Doval I; Giménez-Arnau A; González-Pérez R; Fernández-Redondo V; Serra-Baldrich E; Cordoba-Guijarro S; Gatica-Ortega ME; Silvestre-Salvador JF;
    Contact Dermatitis; 2018 Jan; 78(1):76-82. PubMed ID: 28960334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contact sensitivity to betamethasone 17-valerate and fluocinolone acetonide.
    Pasricha JS; Gupta R
    Contact Dermatitis; 1983 Jul; 9(4):330-1. PubMed ID: 6225621
    [No Abstract]   [Full Text] [Related]  

  • 10. Vasoconstrictor and the anti-inflammatory effects of 7 corticosteroids.
    Crijns MB; Nater JP; van Oostveen F; van der Valk PG
    Contact Dermatitis; 1984 Aug; 11(2):108-11. PubMed ID: 6488765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroid effect on epidermal cell size.
    Delforno C; Holt PJ; Marks R
    Br J Dermatol; 1978 Jun; 98(6):619-23. PubMed ID: 678451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse reaction to a topical steroid transferred by physical contact.
    Stankler L; Bewsher PD
    Br Med J; 1978 Aug; 2(6134):399-400. PubMed ID: 567511
    [No Abstract]   [Full Text] [Related]  

  • 13. [Systemic effects of topically applied hydrocortisone 17-butyrate 21-propionate ointment--comparative studies with betamethasone 17-valerate and hydrocortisone 17-butyrate ointment (author's transl)].
    Takeda K
    Nihon Hifuka Gakkai Zasshi; 1982 Mar; 92(4):503-13. PubMed ID: 7050471
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical glucocorticoids and thinning of normal skin as to be assessed by ultrasound.
    Korting HC
    Curr Probl Dermatol; 1993; 21():114-21. PubMed ID: 8299364
    [No Abstract]   [Full Text] [Related]  

  • 15. Steroid atrophy--a histological appraisal.
    Jones EW
    Dermatologica; 1976; 152 Suppl 1():107-15. PubMed ID: 133833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cushing's syndrome after topical application of corticosteroids.
    Ruiz-Maldonado R; Zapata G; Lourdes T; Robles C
    Am J Dis Child; 1982 Mar; 136(3):274-5. PubMed ID: 7064956
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of dermatitis, stripping, and steroids on the morphology of corneocytes. A new bioassay.
    Hölzle E; Plewig G
    J Invest Dermatol; 1977 Jun; 68(6):350-6. PubMed ID: 864272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids.
    Schäfer-Korting M; Korting HC; Kerscher MJ; Lenhard S
    Clin Pharmacol Ther; 1993 Oct; 54(4):448-56. PubMed ID: 8222488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical corticosteroid allergy in an urban Australian centre.
    Keegel T; Saunders H; Milne R; Sajjachareonpong P; Fletcher A; Nixon R
    Contact Dermatitis; 2004 Jan; 50(1):6-14. PubMed ID: 15059096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side effects of topical glucocorticoids.
    Mills CM; Marks R
    Curr Probl Dermatol; 1993; 21():122-31. PubMed ID: 8299365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.